Six minute test in children and adults with cystic fibrosis

T. Jakovska-Maretti (Skopje), A. Andonovski (Skopje), F. Doksimovski (Skopje)

Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Session: Exploring exercise responses in respiratory diseases
Session type: E-poster session
Number: 937
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Jakovska-Maretti (Skopje), A. Andonovski (Skopje), F. Doksimovski (Skopje). Six minute test in children and adults with cystic fibrosis. 937

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Six minute walk test in children, adolescents and young adults with and without cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011

Can step be a maximal test in children with cystic fibrosis?
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009


Ergospirometry in children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003

Exercise performance in children and young adults with cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 127s
Year: 2001

Multiple breath washout in healthy pre-school children and those with cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002

Comparison of lung function tests in preschoolers with cystic fibrosis and healthy subjects
Source: Annual Congress 2008 - Diagnostic paediatric lung function: technical and clinical aspects
Year: 2008


Exercise testing in adults with cystic fibrosis
Source: Eur Respir Monogr 2018; 80: 216-221
Year: 2018


Diaphragm strength in children and young adults with cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 222s
Year: 2002

Prevalence of tracheobronchomalacia in young children with cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012


NIV for children with cystic fibrosis
Source: ERS Course 2017 - Paediatric noninvasive ventilation
Year: 2017

The clinical significance of oropharyngeal cultures in young children with cystic fibrosis
Source: Eur Respir J, 51 (5) 1800238; 10.1183/13993003.00238-2018
Year: 2018



Polysomnograpgic findings in children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 391s
Year: 2003

Differences between six minute walk test values with obstructed and non obstructed cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 698s
Year: 2004

Comparison of HRCT lung abnormalities with exercise capacity among children and adolescents with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010


Microbiological yield of oropharyngeal swab compared to induced sputum in children with cystic fibrosis (CF) < 5 years of age
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Comparison of lung function during infancy and childhood in children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003

The effect of spirometry on multiple breath washout outcomes in children with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018


Spirometric and plethysmographic measurements in healthy pre-school children and those with cystic fibrosis and chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 224s
Year: 2002

A borderline, or negative sweat test, leads to a diagnostic delay in hypertrypsinaemic cystic fibrosis (CF) infants with mild CFTR mutations
Source: Eur Respir J 2001; 18: Suppl. 33, 124s
Year: 2001

Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Source: ERJ Open Res, 7 (1) 00203-2020; 10.1183/23120541.00203-2020
Year: 2021